Portal Vein Stenting Combined with (125)I Particle Chain Implantation Followed by As(2)O(3) in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus

OBJECTIVE: To evaluate the feasibility and safety of portal vein stenting (PVS) combined with (125)I particle chain implantation and sequential arsenic trioxide (As(2)O(3)) for the treatment of hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT) by transcatheter arterial chemoembo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaonan, Si, Guangyan, Jiao, De-Chao, Han, Xinwei, Zhang, Wenguang, Li, Yahua, Zhou, Xueliang, Liu, Juanfang, Chen, Jianjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013352/
https://www.ncbi.nlm.nih.gov/pubmed/32090088
http://dx.doi.org/10.1155/2020/4109216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013352/
https://www.ncbi.nlm.nih.gov/pubmed/32090088
http://dx.doi.org/10.1155/2020/4109216

Ejemplares similares